TY - JOUR
T1 - Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy
AU - Dyle, Michael C.
AU - Ebert, Scott M.
AU - Cook, Daniel P.
AU - Kunkel, Steven D.
AU - Fox, Daniel K.
AU - Bongers, Kale S.
AU - Bullard, Steven A.
AU - Dierdorff, Jason M.
AU - Adams, Christopher M.
PY - 2014
Y1 - 2014
N2 - Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.
AB - Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.
UR - http://www.scopus.com/inward/record.url?scp=84901466630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901466630&partnerID=8YFLogxK
U2 - 10.1074/jbc.M114.556241
DO - 10.1074/jbc.M114.556241
M3 - Article
C2 - 24719321
AN - SCOPUS:84901466630
SN - 0021-9258
VL - 289
SP - 14913
EP - 14924
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 21
ER -